tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Universal Ibogaine Completes Funding Round

Universal Ibogaine Completes Funding Round

Universal Ibogaine Inc (TSE:IBO) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Universal Ibogaine Inc. has successfully completed a non-brokered private placement, raising $270,000 through the issuance of 13.5 million common shares at $0.02 each. These funds are earmarked for the advancement of their Health Canada clinical trial application for an ibogaine-based treatment for addiction, as well as for general corporate purposes. Additionally, the company has canceled its previous offer to sell common shares at $0.015 each.

For further insights into TSE:IBO stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1